208 related articles for article (PubMed ID: 3080286)
1. Gastric protection by misoprostol against 1300 mg of aspirin. An endoscopic study.
Silverstein FE; Kimmey MB; Saunders DR; Levine DS
Dig Dis Sci; 1986 Feb; 31(2 Suppl):137S-141S. PubMed ID: 3080286
[TBL] [Abstract][Full Text] [Related]
2. Gastric protection by misoprostol against 1,300 mg of aspirin. An endoscopic dose-response study.
Silverstein FE; Kimmey MB; Saunders DR; Surawicz CM; Willson RA; Silverman BA
Am J Med; 1987 Jul; 83(1A):32-6. PubMed ID: 3113243
[TBL] [Abstract][Full Text] [Related]
3. A double-blind study of prophylactic effect of misoprostol on lesions of gastric and duodenal mucosa induced by oral administration of tolmetin in healthy subjects.
Lanza FL
Dig Dis Sci; 1986 Feb; 31(2 Suppl):131S-136S. PubMed ID: 3080285
[TBL] [Abstract][Full Text] [Related]
4. [Acute injury to the gastric mucosa by acetylsalicylic acid. A comparative endoscopic study in man with oral prostaglandin analogs, omeprazole and ranitidine].
Müller P; Dammann HG; Simon B
Arzneimittelforschung; 1986 Feb; 36(2):265-8. PubMed ID: 3083829
[TBL] [Abstract][Full Text] [Related]
5. Comparative mucosal protective properties of misoprostol, cimetidine, and sucralfate.
Bauer RF; Bianchi RG; Casler J; Goldstin B
Dig Dis Sci; 1986 Feb; 31(2 Suppl):81S-85S. PubMed ID: 3080294
[TBL] [Abstract][Full Text] [Related]
6. A blinded endoscopic comparative study of misoprostol versus sucralfate and placebo in the prevention of aspirin-induced gastric and duodenal ulceration.
Lanza F; Peace K; Gustitus L; Rack MF; Dickson B
Am J Gastroenterol; 1988 Feb; 83(2):143-6. PubMed ID: 3124604
[TBL] [Abstract][Full Text] [Related]
7. Antisecretory and mucosal protective actions of misoprostol. Potential role in the treatment of peptic ulcer disease.
Wilson DE
Am J Med; 1987 Jul; 83(1A):2-8. PubMed ID: 3113241
[TBL] [Abstract][Full Text] [Related]
8. [Prophylactic effect of Misoprostol on gastric lesions induced by aspirin (ASA) in healthy subjects].
Naves J; Santoyo R; Morales I
Rev Gastroenterol Mex; 1989; 54(4):203-6. PubMed ID: 2515571
[TBL] [Abstract][Full Text] [Related]
9. Cytoprotection by a synthetic prostaglandin against ethanol-induced gastric mucosal damage. A double-blind endoscopic study in human subjects.
Agrawal NM; Godiwala T; Arimura A; Dajani EZ
Gastrointest Endosc; 1986 Apr; 32(2):67-70. PubMed ID: 3086177
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal cytoprotective effects of misoprostol. Clinical efficacy overview.
Dajani EZ; Nissen CH
Dig Dis Sci; 1985 Nov; 30(11 Suppl):194S-200S. PubMed ID: 3932054
[TBL] [Abstract][Full Text] [Related]
11. [Protective effect of misoprostol on the changes of transgastric potential difference induced by aspirin in man].
Bergmann JF; Simoneau G; Naudin R; Caulin C; Segrestaa JM
Rev Rhum Mal Osteoartic; 1991 Feb; 58(2):135-8. PubMed ID: 1904163
[TBL] [Abstract][Full Text] [Related]
12. Effects of misoprostol, cimetidine, and ethanol on rat gastric plasma volume and morphology.
Lacy ER; Hund P; Tietge J
J Clin Gastroenterol; 1990; 12 Suppl 1():S158-69. PubMed ID: 2120322
[TBL] [Abstract][Full Text] [Related]
13. Misoprostol reduces gastroduodenal injury from one week of aspirin: an endoscopic study.
Jiranek GC; Kimmey MB; Saunders DR; Willson RA; Shanahan W; Silverstein FE
Gastroenterology; 1989 Feb; 96(2 Pt 2 Suppl):656-61. PubMed ID: 2491827
[TBL] [Abstract][Full Text] [Related]
14. Overview of the mucosal protective effects of misoprostol in man.
Dajani EZ
Prostaglandins; 1987; 33 Suppl():117-29. PubMed ID: 3122272
[TBL] [Abstract][Full Text] [Related]
15. Protection by misoprostol against naproxen-induced gastric mucosal damage.
Aadland E; Fausa O; Vatn M; Cohen H; Quinlan D
Am J Med; 1987 Jul; 83(1A):37-40. PubMed ID: 3113244
[TBL] [Abstract][Full Text] [Related]
16. Effects of misoprostol on gastric acid and mucus secretion in man.
Wilson DE; Quadros E; Rajapaksa T; Adams A; Noar M
Dig Dis Sci; 1986 Feb; 31(2 Suppl):126S-129S. PubMed ID: 3080283
[TBL] [Abstract][Full Text] [Related]
17. Healing of benign gastric ulcer. A placebo-controlled comparison of two dosage regimens of misoprostol, a synthetic analog of prostaglandin E1.
Agrawal NM; Saffouri B; Kruss DM; Callison DA; Dajani EZ
Dig Dis Sci; 1985 Nov; 30(11 Suppl):164S-170S. PubMed ID: 3932050
[TBL] [Abstract][Full Text] [Related]
18. Dose-response, meal-stimulated gastric antisecretory study of prostaglandin E1 analog, misoprostol, in man.
Davis GR; Fordtran JS; Dajani EZ
Dig Dis Sci; 1988 Mar; 33(3):298-302. PubMed ID: 3125026
[TBL] [Abstract][Full Text] [Related]
19. Dissociated effects of misoprostol on gastric acid secretion and mucosal blood flow.
Leung FW; Miller JC; Guth PH
Dig Dis Sci; 1986 Feb; 31(2 Suppl):86S-90S. PubMed ID: 3080295
[TBL] [Abstract][Full Text] [Related]
20. The therapeutic efficacy of misoprostol in peptic ulcer disease.
Watkinson G; Hopkins A; Akbar FA
Postgrad Med J; 1988; 64 Suppl 1():60-77. PubMed ID: 3138682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
